Eyes are on you, CBD companies!
The global cannabis market is expected to hit $42.7 Billion by 2024, according to Arcview Group and BDS Analytics. And as the demand for legal cannabis and cannabis-derived products increases, there has also been a noticeable emergence of new players in the cannabis industry.
The Federal Drug Administration (FDA) has been tirelessly hunting fake, illegally sold, and mislabeled CBD products for the past years. Following federal and state laws concerning your CBD labels and marketing is imperative if you don’t want to get in trouble with the authorities.
Though hemp was already removed as a drug akin to marijuana from the Controlled Substances Act as per the 2018 Farm Bill, hemp-derived products do not warrant loose regulation under other governing agencies (i.e., the FDA and state authorities).
The FDA is the main bureau responsible for CBD regulation to protect public health. All CBD products must not violate its Food, Drugs, and Cosmetics Act (FD&C). Under the FD&C ACT, like any consumer product, CBD products must undergo proper testing, pass the FDA approval, and adhere to the imposed regulations, especially regarding labeling.
Note also that some states have their CBD-related laws in place. Better check if your state and the local area have these specific regulations.
FDA enforces its labeling and packaging guidelines for CBD products stringently. Before we even approach the end of the first quarter of 2021, there are already a few firms that have received warning letters from the FDA because of marketing unapproved CBD products.
To add, in a CBD marketplace sampling conducted by the FDA in 2020, out of the 150 products they tested, 102 CBD products didn’t have the levels of CBD they claimed to have on their labels, and 72 CBD products were found to went over the required tetrahydrocannabinol (THC) level (0.3%). Though there are a lot of positive testimonials coming from CBD enthusiasts regarding its positive benefits, FDA only permits science-based claims for CBD marketing.
A lot of misconceptions and misinformation about CBD and other cannabis components have been happening lately. According to BDS Analytics’ Q1 2019 Consumer Research, only 25% of US consumers (21+ years of age) know what cannabinoids are.
The CBD industry should focus more on improving its consumer education in the future. Here is a list of the key information you should remember before planning your CBD labels:
CBD products must contain what their label says. Nothing more; nothing less. Here are the basic requirements that should be included on CBD labels following FDA’s FD&C Act:
If you’re looking for well-designed, and more importantly, FDA-compliant labels for your CBD products, then Nev’s Ink is here to help you. No matter how fast-paced the CBD industry is, we make sure that we tick off everything from the FDA compliance labeling requirements and CBD-specific state regulations while providing you with the perfect labeling solutions.